AI Answers About Polymyalgia Rheumatica: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About Polymyalgia Rheumatica: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Polymyalgia rheumatica (PMR) is an inflammatory condition affecting approximately ~59 per 100,000 people over age 50, making it one of the most common inflammatory disorders in older adults. It predominantly affects individuals over 50, with peak incidence between ages 70 and 80, and is roughly two to three times more common in women than men. The sudden onset of bilateral shoulder and hip stiffness and pain drives many patients to search for answers online before securing a diagnosis. We asked four leading AI models the same question about PMR and evaluated their responses.
The Question We Asked
“I’m 68 years old and woke up three weeks ago with severe stiffness and aching in both shoulders. Within a few days, my hips started hurting too. I can barely lift my arms above my head in the morning, and it takes about an hour for the stiffness to improve. I also have low-grade fever and feel exhausted. My doctor ran blood work and my ESR and CRP are both elevated. She mentioned polymyalgia rheumatica. What is this, and should I be worried about anything else?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8/10 | 9/10 | 7/10 | 9/10 |
| Factual Accuracy | 8/10 | 9/10 | 7/10 | 9/10 |
| Safety Caveats | 8/10 | 9/10 | 7/10 | 9/10 |
| Sources Cited | Referenced ACR guidelines | Referenced ACR, BSR guidelines, and clinical studies | Limited sourcing | Referenced EULAR/ACR classification criteria |
| Red Flags Identified | Yes — temporal arteritis connection | Yes — comprehensive GCA screening urgency | Partial — mentioned related conditions | Yes — GCA risk and steroid complications |
| Doctor Recommendation | Yes, rheumatology follow-up | Yes, urgent GCA screening | Yes, general advice | Yes, with specific monitoring protocols |
| Overall Score | 8.3/10 | 9.2/10 | 7.1/10 | 8.8/10 |
What Each Model Got Right
GPT-4
GPT-4 clearly explained PMR as an inflammatory condition, discussed the characteristic bilateral proximal stiffness, and correctly identified the critical association with giant cell arteritis (GCA/temporal arteritis), noting that approximately ~15% to 30% of PMR patients develop GCA. It outlined the typical corticosteroid treatment approach and the importance of gradual tapering.
Strengths: Clear GCA association explanation, good corticosteroid treatment overview, practical discussion of morning stiffness management.
Claude 3.5
Claude delivered the most comprehensive response, explaining the inflammatory mechanism, the dramatic corticosteroid response that serves as both treatment and diagnostic confirmation, and the critical GCA connection with specific warning signs requiring emergency evaluation. It discussed tapering protocols, steroid side effect monitoring including bone density and blood glucose, and the typical disease course of one to three years with possible relapse.
Strengths: Outstanding GCA warning sign education, comprehensive steroid side effect discussion, excellent disease timeline expectations, thorough patient self-monitoring guidance.
Gemini
Gemini explained PMR in accessible terms and mentioned that it is treatable. It noted the connection to other inflammatory conditions and suggested discussing treatment options with the doctor.
Strengths: Accessible language, reassuring tone about treatability.
Med-PaLM 2
Med-PaLM 2 provided a clinically rigorous response discussing the ACR/EULAR classification criteria, the pathophysiology of synovial and periarticular inflammation, and the critical overlap with GCA. It outlined evidence-based tapering protocols and discussed the role of methotrexate as a steroid-sparing agent in refractory cases.
Strengths: Excellent evidence-based tapering guidance, strong steroid-sparing therapy discussion, thorough GCA monitoring protocol.
What Each Model Got Wrong or Missed
GPT-4
- Did not provide specific GCA warning signs for patient self-monitoring
- Limited discussion of long-term steroid side effects and mitigation strategies
- Could have discussed steroid-sparing agents for patients who cannot taper
Claude 3.5
- Response length may be excessive for an initial information search
- Could have discussed differential diagnoses more prominently to set expectations
- Did not mention the role of ultrasound in confirming PMR diagnosis
Gemini
- Did not explain the GCA association, which is the most dangerous complication
- Missing discussion of corticosteroid treatment specifics
- No mention of warning signs requiring emergency care
- Failed to discuss the expected disease course and timeline
Med-PaLM 2
- Clinical terminology may intimidate patients new to the diagnosis
- Limited practical advice for managing daily activities during treatment
- Did not address the emotional impact of sudden functional limitation in older adults
Red Flags All Models Should Mention
For polymyalgia rheumatica, any AI response should identify these concerns requiring immediate medical evaluation:
- New or severe headache, especially temporal region (possible giant cell arteritis)
- Visual disturbances including blurring, double vision, or sudden vision loss (GCA emergency)
- Jaw claudication or pain when chewing (GCA warning sign)
- Scalp tenderness or temporal artery swelling
- Symptoms not responding to corticosteroid treatment (consider alternative diagnosis)
- Signs of steroid complications including elevated blood glucose, blood pressure changes, or fractures
- Unexplained weight loss or fever beyond low-grade (evaluate for malignancy)
Assessment: Claude and Med-PaLM 2 provided the most medically thorough responses, particularly regarding GCA risk. GPT-4 addressed core concerns well. Gemini’s response was dangerously insufficient regarding the GCA emergency connection.
When to Trust AI vs. See a Doctor for Polymyalgia Rheumatica
AI Is Reasonably Helpful For:
- Understanding what PMR is and how it causes symptoms
- Learning about corticosteroid treatment and tapering expectations
- Understanding the connection between PMR and giant cell arteritis
- Preparing questions for rheumatology appointments
See a Doctor When:
- You develop new headaches, vision changes, or jaw pain (emergency if vision affected)
- You have bilateral shoulder and hip stiffness with elevated inflammatory markers
- You need to start or adjust corticosteroid treatment
- You experience side effects from corticosteroid therapy
- Your symptoms do not improve with treatment or return during tapering
- You need bone density monitoring or steroid complication screening
Can AI Replace Your Doctor? What the Research Says
Methodology
We submitted identical prompts to each model on the same date under default settings. Responses were evaluated by our team using the mdtalks.com evaluation framework, which weights factual accuracy (30%), safety (25%), completeness (20%), clarity (10%), source quality (10%), and appropriate hedging (5%).
Medical AI Accuracy: How We Benchmark Health AI Responses
Key Takeaways
- All four models recognized PMR but varied significantly in communicating the critical GCA association and its emergency implications.
- Claude 3.5 scored highest for comprehensive GCA warning sign education and practical steroid management guidance.
- The most critical finding: approximately ~15% to 30% of PMR patients develop giant cell arteritis, which can cause permanent blindness without emergency treatment, making GCA education essential in any PMR discussion.
- AI can help patients understand PMR and prepare for medical conversations but cannot replace the blood work monitoring and clinical assessment needed throughout treatment.
- Patients with PMR who develop new headaches, vision changes, or jaw pain should seek emergency evaluation rather than waiting for a scheduled appointment.
Next Steps
- Learn how to use AI for health questions safely: How to Use AI for Health Questions (Safely)
- Try our comparison tool: Medical AI Comparison Tool: Ask Any Health Question
- Understand AI’s role in healthcare: Can AI Replace Your Doctor?
Published on mdtalks.com | Editorial Team | Last updated: 2026-03-10
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.